Tuesday, 24th October 33rd ASM of the Australian & New Zealand Bone & Mineral Society 2023

• Food for thought on the therapeutic regimen after stopping denosumab in postmenopausal women - Yumie Rhee

• An implementation science approach to community pharmacy osteoporosis screening - Jonathan Phuong
• Rate of bone loss is associated with fracture risk: The Study of Osteoporotic Fractures - Krisel De Dios
• Skeletal effects of neratinib treatment and Blautia luti supplementation in tibial trabecular bone of albino Wistar rats - Micaela Quinn
• Severe Low Bone Mineral Density is Common in Patients with Beta Thalassaemia Major: A Single Centre Experience  - Mike Lin
• Quantification of abnormal cortical bone surface remodelling in preclinical models of arthritis - Pholpat Durongbhan
• Association between knee osteoarthritis and volumetric bone mineral density - Khuong-Duy Hoang
• Gestational vitamin D and offspring fracture risk: Do associations persist into mid adolescence? - Mia Percival
• Estimating “Skeletal Age” by Bone Loss in Elderly Men and Women - Ngoc Huynh
• Does long-term antiresorptive administration lead to atypical fractures at other skeletal sites excluded from the ASBMR atypical femur fracture (AFF) case definition? A systematic review - Lucy Collins

An implementation science approach to community pharmacy osteoporosis screening - Jonathan Phuong
Rate of bone loss is associated with fracture risk: The Study of Osteoporotic Fractures - Krisel De Dios
Skeletal effects of neratinib treatment and Blautia luti supplementation in tibial trabecular bone of albino Wistar rats - Micaela Quinn
Severe Low Bone Mineral Density is Common in Patients with Beta Thalassaemia Major: A Single Centre Experience  - Mike Lin
Quantification of abnormal cortical bone surface remodelling in preclinical models of arthritis - Pholpat Durongbhan
Association between knee osteoarthritis and volumetric bone mineral density - Khuong-Duy Hoang
Gestational vitamin D and offspring fracture risk: Do associations persist into mid adolescence? - Mia Percival
Antipsychotic medication use and fracture: a case-control study - Behnaz Azimi Manavi
Estimating “Skeletal Age” by Bone Loss in Elderly Men and Women - Ngoc Huynh
Does long-term antiresorptive administration lead to atypical fractures at other skeletal sites excluded from the ASBMR atypical femur fracture (AFF) case definition? A systematic review - Lucy Collins

• Generating cell-based models of FGFR3-related diseases - Julian FH Chu
• Investigating early-onset osteoporosis in individuals with Down syndrome - Michelle Maugham-Macan
• A systematic review of parameters used for the assessment of subchondral bone in osteoarthritis (OA) with computed tomography (CT) - Jemima E. Schadow
• Bone mineral density and sedentary ageing: a cross-sectional analysis - Kara B Anderson
• Cortical bone mineralization density distribution in paediatics – can peripheral QCT images act as a pain-free bone biopsy? - Julie Briody
• Quality of life (QoL) and transition care for patients with Osteogenesis imperfecta (OI) and X-linked hypophosphataemia (XLH) - Lucy Collins
• Immunoengineering for periodontal tissue regeneration - Yinghong Zhou
• Severe osteoporosis in a female with type 1 diabetes and pancreatic exocrinopathy with chronic malabsorption and vitamin D deficiency. - Jeremy Knott
• Incidence and prevalence of osteoporotic fracture in adult lung transplant recipients: a single centre audit - Shanal Kumar
• Prevalence of diagnosable depression in patients awaiting orthopaedic specialist consultation: a cross-sectional analysis - Itamar Levinger
• BONEcheck: a digital tool for personalized bone health assessment - Dinh-Tan Nguyen
• Coronary artery calcification is associated with smaller increases in femoral neck bone mineral density in patients on anti-resorptive therapy - Alexander J. Rodriguez
• Associations Between Social Disadvantage and Bone, Muscle, and Physical Function Outcomes in Community-Dwelling Older Adults: The SEBA Study - Jason Talevski
• Associations between sarcopenia and domains of quality of life in older adults - Kara Anderson
• A qualitative assessment of healthcare professionals bone health knowledge and management of people with multiple sclerosis - Ayse Zengin
• MET-Call during Zoledronate Infusion: An Unusual Case of Allergy - Sharjeel SA Ahmad
• Broken bones, miserable moans, and unfortunate unknowns - Tomasz J Block
• Severe hypocalcaemia postoperatively from a laryngectomy, total thyroidectomy and total parathyroidectomy requiring Teriparatide - Liam Clifford
• Management of osteoporosis and fracture risk in a 30-year-old 6 months post-partum woman with adult-onset hypophosphatasia (HPP)   - Tavleen Kaur
• Bone microarchitecture and disorganized bone tissue in a young woman with pycnodysostosis and an atypical femur fracture: A case report - Cat Shore-Lorenti
• Fragile Foundations: A Genetic Cause of Osteoporosis - Felicity Stringer
• Concurrent denosumab and parenteral iron therapy precipitating severe hypocalcaemia and hypophopshataemia: a case report - Sylvia Ye

• In vivo phosphoproteomics and functional genomics of insulin signalling in bone - Benjamin Parker
• Single-cell RNA sequencing: unravelling the bone one cell at a time - Ryan C Chai

• Frailty is associated with greater long-term risk for fall and fracture-related hospitalisations as well as mortality in community-dwelling older Australian women - Marc Sim
• RANKL inhibition creates a pro-osteoclastic environment, leading to an overshoot in serum TRAP and accelerated bone resorption following treatment withdrawal. - MICHELLE MCDONALD
• Preventing Bone and Muscle Injury and Reducing Costs in Australian Army Recruit Training with Bone-Targeted Pre-Conditioning: The PREFIT Study - Belinda Beck
• Deletion of the chondrocyte glucocorticoid receptor attenuates cartilage degradation through suppression of early synovial activation in murine posttraumatic osteoarthritis - Eugenie Macfarlane
• Effects of high-intensity resistance and impact exercise on changes in body composition and metabolic and musculoskeletal health during weight loss in older adults with obesity: A pilot randomised controlled trial - Jakub Mesinovic

• Use of denosumab in non-osteoporotic conditions including bone tumours and paediatric use - Joel A Vanderniet
• Hypophosphatasia in the age of miracles - Syndia Lazarus

• Impact of HIV on radial bone density, geometry, and strength in midlife Zimbabwean women and association between pQCT outcomes and fracture - Mícheál Ó Breasail
• Reversing high bone porosity in NF1 bone using dietary supplements - Aaron Schindeler
• Assessing the robustness of evidence for the efficacy of anti-fracture  medications - Nick Tran
• Sclerostin, a marker for mature fibrochondrocytes, modulates the stiffness gradient to maintain tissue integrity of the fibrocartilaginous enthesis. - Shinsei Yambe
• “Skeletal Age” for mapping the impact of fracture on mortality using clinical data - Thach Tran

• Bone marrow adipose tissue under control of nutrient sensors - Michaela Tencerova